MedTrace Logo

Fetal Neurobehavior in Non-methadone Maintained Women in Substance Abuse Treatment

NCT00522626 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 19

Last updated 2016-03-01

Study results available
· View outcomes & findings →

Summary

This study seeks to elucidate fetal neurobehavioral development in fetuses of opioid dependent women who have either undergone and completed methadone detoxification,or who never received methadone maintenance, and are not methadone maintained at 36 weeks gestation. This research will determine how fetal neurobehavioral functioning in fetuses of opioid dependent, non-methadone maintained women differs from that of fetuses whose opioid dependent mothers are methadone maintained. The project will utilize a state-of-the-art computerized fetal actocardiograph and data analysis program to simultaneously evaluate fetal movement and heart rate, the interaction between the two and maternal physiologic parameters.

Conditions

  • Pregnancy
  • Drug Abuse

Interventions

DEVICE

Maternal fetal monitoring

Simultaneous monitoring of maternal and fetal physiology

Sponsors & Collaborators

Principal Investigators

  • Lauren M Jansson, MD · Johns Hopkins University

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-08-31
Primary Completion
2010-02-28
Completion
2010-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00522626 on ClinicalTrials.gov